Pharmacokinetics, Safety, and Tolerability of Single‐Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study-Reference-Cited by-同舟云学术

Pharmacokinetics, Safety, and Tolerability of Single‐Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study

Published:2019-01-25 Issue:5 Volume:59 Page:654-667
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Stass Heino¹,Lettieri John²,Vanevski Konstantina M.³,Willmann Stefan¹,James Laura P.⁴,Sullivan Janice E.⁵,Arrieta Antonio C.⁶,Bradley John S.⁷

Affiliation:

1. Bayer Wuppertal Germany

2. Bayer Whippany NJ USA

3. Bayer Basel Switzerland

4. Department of PediatricsUniversity of Arkansas for Medical Science and Arkansas Children's Research Institute Little Rock AR USA

5. University of Louisville/Kosair Charities Pediatric Clinical Research Unit/Norton Children's Hospital Louisville KY USA

6. Children's Hospital of Orange County Orange CA USA

7. University of CaliforniaSan Diego School of Medicine and Rady Children's Hospital San Diego San Diego CA USA

Funder

Bayer AG

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1358

Reference48 articles.

1. Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in Canada

2. HackelM BhagwatS KhandeH JoshiP PatelM SahmD.In vitro activity of WCK 771 a new benzoquinolizine quinolone in development against key bacterial groups from the USA and Europe. Presented at the 55th Interscience Conference of Antimicrobial Agents and Chemotherapy in San Diego CA September 17‐21 2015. Poster F‐1196.

3. HawserS HackelM BouchillonS VenteA.Comparative activity of finafloxacin and moxifloxacin against anaerobes. Presented at the 24th European Congress of Clinical Microbiology and Infectious Diseases in Barcelona Spain May 10‐13 2014. Poster E‐113.

4. Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features

5. Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colorimetric detection of sitagliptin and moxifloxacin using AgNPs modified by 4-mercaptophenylbronic acid;Inorganic Chemistry Communications;2024-09

2. Systematic review on the safety of the use of quinolones in the pediatric population;Salud, Ciencia y Tecnología - Serie de Conferencias;2024-06-21

3. Safety and tolerability of moxifloxacin in pediatric population: A systematic review of evidence based practice;Tropical Journal of Pharmaceutical Research;2024-04-14

4. Developmental Pharmacokinetics of Antibiotics Used in Neonatal ICU: Focus on Preterm Infants;Biomedicines;2023-03-17

5. Antibacterial Agents;Principles and Practice of Pediatric Infectious Diseases;2023